| Literature DB >> 28830556 |
Na Du1, Shumin Liu1, Min Niu1, Yong Duan1, Shuangmeng Zhang1, Jing Yao1, Jian Mao1, Ran Chen1, Yan Du2.
Abstract
BACKGROUND: In recent years, New Delhi metallo-beta-lactamases 1 (bla NDM-1) has been reported with increasing frequency and become prevalent. The present study was undertaken to investigate the epidemiological dissemination of the bla NDM-1 gene in Enterobacter cloacae isolates at a teaching hospital in Yunnan, China.Entities:
Keywords: Enterobacter cloacae; ISCR1; Integron; NDM-1; ST74
Mesh:
Substances:
Year: 2017 PMID: 28830556 PMCID: PMC5568220 DOI: 10.1186/s12941-017-0232-y
Source DB: PubMed Journal: Ann Clin Microbiol Antimicrob ISSN: 1476-0711 Impact factor: 3.944
Clinical characteristics of the cases
| Isolates | Age (years) | Gender | Specimen | Ward | Average hospital stay (days) | History of travel epidemic area | Outcome |
|---|---|---|---|---|---|---|---|
| T1 | 58 | Male | Secreta | Orthopedics Department | 66 | No | Discharge |
| T2 | 96 | Male | Sputum | General Practice | 33 | No | Discharge |
| T3 | 87 | Female | Urine | EICU | 117 | No | Death |
| T4 | 36 | Female | Urine | Transplantation Center | 20 | No | Discharge |
| T5 | 32 | Male | Urine | Transplantation Center | 39 | No | Discharge |
| T6 | 65 | Female | Pleural effusion | EICU | 1 | No | Death |
| T7 | 32 | Male | Urine | Transplantation Center | 23 | No | Discharge |
| T8 | 22 | Female | Urine | Transplantation Center | 35 | No | Discharge |
| T9 | 11 | Female | Blood | NICU | 18 | No | Discharge |
| T10 | 34 | Male | Urine | Transplantation Center | 32 | No | Discharge |
EICU emergency intensive care unit, NICU neonatal intensive care unit
Primers used in PCR and DNA sequencing
| Gene | Nucleotide sequence (5′ to 3′) | Expected size of amplicon (bp) | Reference or source |
|---|---|---|---|
| intI1/intI1 | F1: GCATCCTCGGTTTTCTGG | 457 | [ |
| intI2/intI2 | F2: CACGGATATGCGACA AAA AGGT | 789 | [ |
| intI3/intI3 | F3: ATCTGCCAA ACCTGACTG | 922 | [ |
| hep58/hep59 | F4: TCATGGCTTGTTATGACTGT | Unknown | [ |
| hep74/hep51 | F5: CGGGATCCCGGACGGCATGCACGATTTGTA | Unknown | [ |
| orf513F/orf513R | F6: ATGGTTTCATGCGGGTT | 475 | [ |
| orf513F/sul1R | F7: ATGGTTTCATGCGGGTT | Unknown | [ |
Antimicrobial drug susceptibility profiles (MICs in mg/L) for clinical isolates and transconjugants
| Isolate no. | VITEK2 | E test | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PIP | TCY | ATM | CAZ | CIP | AMK | MEM | IMP | ETP | TGC | MEM | IMP | ETP | |
| T1 | ≥128 | ≥16 | ≥64 | ≥64 | ≥4 | 16 | 8 | 8 | ≥8 | 1 | >32 | 32 | >32 |
| T2 | ≥128 | 4 | ≥64 | ≥64 | ≥4 | ≤2 | ≥16 | ≥16 | ≥8 | 1 | >32 | >32 | >32 |
| T3 | ≥128 | ≥16 | ≥64 | ≥64 | ≥4 | ≥64 | 8 | ≥16 | ≥8 | ≥8 | >32 | >32 | >32 |
| T4 | ≥128 | 8 | ≥64 | ≥64 | ≥4 | 4 | ≥16 | ≥16 | ≥8 | 1 | >32 | 24 | >32 |
| T5 | ≥128 | ≥16 | 16 | ≥64 | ≥4 | 4 | ≥16 | ≥16 | ≥8 | 2 | >32 | >32 | >32 |
| T6 | ≥128 | ≥16 | ≥64 | ≥64 | ≥4 | 16 | ≥16 | ≥16 | ≥8 | 1 | 32 | >32 | >32 |
| T7 | ≥128 | ≥16 | 16 | ≥64 | ≥4 | 16 | ≥16 | ≥16 | ≥8 | 2 | >32 | >32 | >32 |
| T8 | ≥128 | ≥16 | ≥64 | ≥64 | ≥4 | 16 | ≥16 | ≥16 | ≥8 | 1 | >32 | >32 | >32 |
| T9 | ≥128 | ≥16 | ≤1 | ≥64 | 0.5 | ≤2 | ≥16 | ≥16 | ≥8 | 1 | >32 | >32 | >32 |
| T10 | ≥128 | 4 | ≥64 | ≥64 | ≥4 | ≤2 | 4 | 4 | ≥8 | 2 | 6 | 8 | 8 |
| T1-EC600 | ≥128 | ≤1 | ≤1 | ≥64 | 0.5 | ≤2 | 8 | ≥16 | ≥8 | 1 | 8 | 8 | 8 |
| T2-EC600 | ≥128 | ≤1 | 32 | ≥64 | 0.5 | ≤2 | ≥16 | ≥16 | ≥8 | 1 | 8 | 16 | >32 |
| T3-EC600 | ≥128 | ≤1 | ≤1 | ≥64 | 0.5 | ≤2 | 8 | ≥16 | ≥8 | 2 | 16 | 16 | >32 |
| T4-EC600 | ≥128 | ≥16 | 32 | ≥64 | 0.5 | ≤2 | 8 | ≥16 | ≥8 | 1 | >32 | 6 | 8 |
| T5-EC600 | ≥128 | ≤1 | ≤1 | ≥64 | 0.5 | ≤2 | 8 | ≥16 | ≥8 | 2 | >32 | >32 | >32 |
| T6-EC600 | ≥128 | ≤1 | ≤1 | ≥64 | 0.5 | ≤2 | ≥16 | ≥16 | ≥8 | 1 | >32 | >32 | >32 |
| T7-EC600 | ≥128 | ≤1 | ≤1 | ≥64 | 0.5 | ≤2 | ≥16 | ≥16 | ≥8 | 1 | 24 | 8 | 8 |
| T8-EC600 | ≥128 | ≤1 | ≤1 | ≥64 | 0.5 | ≤2 | 8 | ≥16 | ≥8 | 1 | >32 | >32 | >32 |
| T9-EC600 | ≥128 | ≤1 | ≤1 | ≥64 | 0.5 | ≤2 | ≥16 | ≥16 | ≥8 | 1 | 24 | >32 | 24 |
| T10-EC600 | ≥128 | ≤1 | ≤1 | ≥64 | 0.5 | ≤2 | ≥16 | ≥16 | ≥8 | 1 | >32 | >32 | 16 |
| EC600 | ≤4 | ≤1 | ≤1 | ≤1 | ≤0.25 | ≤2 | ≤0.25 | ≤1 | ≤0.5 | ≤0.5 | 0.032 | 0.019 | 0.008 |
| ATCC25922 | ≤4 | ≤1 | ≤1 | ≤1 | ≤0.25 | ≤2 | ≤0.25 | ≤1 | ≤0.5 | ≤0.5 | 0.032 | 0.019 | 0.008 |
EC600 Escherichia coli 600, T1-EC600 the transconjugants of T1 strain, PIP piperacillin, TCY tetracycline, ATM aztreonam, CAZ ceftazidime, CIP ciprofloxacin, AMK amikacin, MEM meropenem, IPM imipenem, ETP ertapenem, TGC tigecycline
Fig. 1Pulsed-field gel electrophoresis (PFGE) of XbaI-digested DNA of E. cloacae isolates. Lane M PFGE marker, Salmonella ser. Braenderup H9812; lanes 1–10 representative NDM-1-producing E. cloacae
Fig. 2Results of S1 nuclease PFGE and Southern blot hybridization. Lane M PFGE marker, Salmonella ser. Braenderup H9812; lanes 1–7 Strains (T1–T7) digested with S1 nuclease; lanes 8–14 hybridized plasmids of strains (T7–T1) with the bla NDM-1 probe; lanes 15–17 strains (T8–T10) digested with S1 nuclease; lanes 18–20 hybridized plasmids of strains (T8–T10) with the bla NDM-1 probe